Eli Lilly in deal to supply COVID-19 drugs to low-income countries

INDIANA: Eli Lilly and Co said on Thursday it had entered into an agreement with the Bill & Melinda Gates Foundation for potential supply of its experimental antibody treatments for COVID-19 to low and middle-income countries.

As part of the deal, Lilly said it will make antibody therapies available to lower-income countries prior to April 2021, but did not elaborate on the number of doses. Separately, Fujifilm Holdings Corp said its facility in Denmark would manufacture treatments next year.Lilly had previously said it would make one million doses of its single antibody treatment available by the end of the year, and another 50,000 doses of its dual-antibody therapy by the fourth quarter this year.

Lilly said its partners with which it is developing antibody therapies, including Canadian biotech company AbCellera Biologics Inc, had agreed to waive their royalties on the therapies distributed in low- and middle-income countries. The drugmaker in September partnered with Amgen Inc to increase supply of its antibody therapies, a day after data showed that Lilly's single antibody therapy, LY-CoV555, helped cut hospitalisation and emergency room visits for COVID-19 patients.READ: Europe buys Gilead's remdesivir for 500,000 COVID-19 patients amid supply worries

Fujifilm said in a statement it expects to begin manufacturing of Lilly's antibody therapy in April 2021. In June, the company said its subsidiary Fujifilm Diosynth Biotechnologies would double capacity at its Danish facility, which it has pledged to use in making COVID-19 treatments.A dual-antibody combination also showed similar results on Wednesday. Lilly plans to seek US emergency use authorisation for that combination next month.

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Eli Lilly in deal to supply Covid-19 drugs to low-income countriesWASHINGTON (REUTERS) - Eli Lilly and Co said on Thursday (Oct 8) it had entered into an agreement with the Bill & Melinda Gates Foundation for potential supply of its experimental antibody treatments for Covid-19 to low and middle-income countries.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Eli Lilly in deal to supply Covid-19 drugs to low-income countriesWASHINGTON (REUTERS) - Eli Lilly and Co said on Thursday (Oct 8) it had entered into an agreement with the Bill & Melinda Gates Foundation for potential supply of its experimental antibody treatments for Covid-19 to low and middle-income countries.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

EU's potential COVID-19 vaccine doses top 1 billion with Johnson & Johnson dealThe European Union has sealed a deal with Johnson & Johnson to supply up to 400 million doses of its potential COVID-19 vaccine, as the bloc ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Europe buys Gilead's remdesivir for 500,000 COVID-19 patients amid supply worriesGilead Sciences said on Thursday it had agreed to sell Europe up to 500,0000 courses of its antiviral drug remdesivir, as the continent scrambles ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Britain's Covid-19 testing system hit by Roche supply chain glitchLONDON (REUTERS) - Britain's Covid-19 testing system faced more disruption on Wednesday (Oct 7) after Swiss pharmaceutical giant Roche said problems at a new warehouse had delayed the dispatch of some products at a time case numbers are surging.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Targeted movement control is best way to deal with Malaysia's spike in Covid-19 cases: ExpertsKUALA LUMPUR - Having set record highs in daily coronavirus cases for two straight days this week, murmurs have grown of an impending lockdown in Malaysia, similar to the one implemented for three months earlier this year.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »